ADS Health: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ADS Health
Largest movements
- Receivables within one year +€9,070
up €9,070 (+121%), from €7,505 to €16,574
of which Trade receivables: +€5,348
- Cash -€3,668
down €3,668 (-67.4%), from €5,442 to €1,774
mainly Receivables within one year (-€9,070) and Other debts (-€4,382)
- Profit (loss) carried forward +€7,349
up €7,349 (+34.8%), from -€21,106 to -€13,757
- Other debts -€4,382
down €4,382 (-81.2%), from €5,395 to €1,013
- Trade debts -€2,822
down €2,822 (-12.6%), from €22,445 to €19,623
- Tax, wage and social debts +€2,756
up €2,756 (+2,200%), from €125 to €2,881
- Accrued charges and deferred income +€2,500
new in 2025: €2,500
- Gross operating margin +€8,618
up €8,618 (+76.0%), from €11,336 to €19,954
- Other operating charges -€5,703
down €5,703 (-30.9%), from €18,465 to €12,762
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €13,202 | €18,603 | +€5,401 | +40.9% |
| Fixed assets | 21/28 | €255 | €255 | = | 0.0% |
| Financial fixed assets | 28 | €255 | €255 | = | 0.0% |
| Current assets | 29/58 | €12,947 | €18,348 | +€5,401 | +41.7% |
| Amounts receivable within one year | 40/41 | €7,505 | €16,574 | +€9,070 | +121% |
| Trade receivables | 40 | €5,283 | €10,631 | +€5,348 | +101% |
| Other amounts receivable | 41 | €2,222 | €5,943 | +€3,722 | +168% |
| Cash at bank and in hand | 54/58 | €5,442 | €1,774 | -€3,668 | -67.4% |
| Total equity and liabilities | 10/49 | €13,202 | €18,603 | +€5,401 | +40.9% |
| Equity | 10/15 | -€14,764 | -€7,414 | +€7,349 | +49.8% |
| Contributions | 10/11 | €6,210 | €6,210 | = | 0.0% |
| Reserves | 13 | €132 | €132 | = | 0.0% |
| Non-distributable reserves | 130/1 | €132 | €132 | = | 0.0% |
| Reserves not available under the articles | 1311 | €132 | €132 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€21,106 | -€13,757 | +€7,349 | +34.8% |
| Amounts payable | 17/49 | €27,966 | €26,017 | -€1,948 | -7.0% |
| Amounts payable within one year | 42/48 | €27,966 | €23,517 | -€4,448 | -15.9% |
| Trade debts | 44 | €22,445 | €19,623 | -€2,822 | -12.6% |
| Suppliers | 440/4 | €22,445 | €19,623 | -€2,822 | -12.6% |
| Taxes, remuneration and social security | 45 | €125 | €2,881 | +€2,756 | +2,200% |
| Taxes | 450/3 | €125 | €2,881 | +€2,756 | +2,200% |
| Other amounts payable | 47/48 | €5,395 | €1,013 | -€4,382 | -81.2% |
| Accrued charges and deferred income | 492/3 | - | €2,500 | +€2,500 | |
| Other operating charges | 640/8 | €18,465 | €12,762 | -€5,703 | -30.9% |
| Gross operating margin | 9900 | €11,336 | €19,954 | +€8,618 | +76.0% |
| Operating profit (loss) | 9901 | -€7,129 | €7,192 | +€14,321 | |
| Financial income | 75/76B | €453 | €332 | -€121 | -26.7% |
| Recurring financial income | 75 | €453 | €332 | -€121 | -26.7% |
| Financial charges | 65/66B | €143 | €174 | +€31 | +22.0% |
| Recurring financial charges | 65 | €143 | €174 | +€31 | +22.0% |
| Profit (loss) for the period before taxes | 9903 | -€6,819 | €7,349 | +€14,168 | |
| Income taxes | 67/77 | €0 | - | = | |
| Profit (loss) for the period | 9904 | -€6,819 | €7,349 | +€14,168 | |
| Profit (loss) for the period to be appropriated | 9905 | -€6,819 | €7,349 | +€14,168 |
Source: filed annual accounts (NBB), financial years ended 31 March 2024 and 31 March 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.